 | Vol. 12.45 – 3 December, 2024 |
| |
|
|
| Researchers assessed the safety and activity of CTX130, a CD70-directed, allogeneic CAR immunotherapy manufactured from healthy donor T cells, in patients with relapsed or refractory T cell lymphoma. [Lancet Oncology] |
|
|
|
 | PUBLICATIONSListed by the impact factor of the journal |
|
|
|
| Researchers determined the frequency and within-patient variability of corticosteroid-responsive type 1 (T1)-high, T2-high, and T1/T2-high asthma endotypes and whether virally influenced T1-high disease influenced corticosteroid response in asthma. [American Journal of Respiratory and Critical Care Medicine] |
|
|
|
| ARTISTRY-1 was a Phase II/III, operationally seamless, randomized, open-label, multicenter, active-controlled study. Phase II of the study enrolled adults with plasma HIV-1 RNA <50 copies/mL receiving a complex antiretroviral therapy regimen for ≥6 months. [Clinical Infectious Diseases] |
|
|
|
| The importance of calcium as a second messenger in T cell signaling was exemplified by genetic deficiencies of STIM1 and ORAI1, which abolished store-operated calcium entry resulting in combined immunodeficiency. [Journal of Experimental Medicine] |
|
|
|
| Researchers described novel trivalent antibodies, DNA-encoded tri-specific T cell engagers, targeting two glioblastoma multiforme antigens, epidermal growth factor receptor variant III (EGFRvIII) and IL-13Rα2, and engaging T cells through CD3. [Journal for Immunotherapy of Cancer] |
|
|
|
| Scientists comprehensively analyzed paired single-cell RNA transcriptome and T cell repertoire profiles from 14 hepatocellular carcinoma ascites samples, collected from seven patients before and after treatment with the combination of sintilimab and bevacizumab. [Journal for Immunotherapy of Cancer] |
|
|
|
| Investigators analyzed long-term clinical and biomarker features of anti-contactin-1 (CNTN1) autoimmune nodopathy. Patients with anti-CNTN1+ autoimmune nodopathy detected in the laboratory from which clinical information was available were included. [Annals of Neurology] |
|
|
|
| Triggered by findings indicating a correlation between proton pump inhibitors usage and susceptibility to infectious or autoimmune diseases, investigators studied the impact of a pharmacological concentration of omeprazole on human CD4+ T cells. [International Immunopharmacology] |
|
|
|
| Scientists assessed whether B cells present in peripheral blood mononuclear cells responded to vaccines and reflected the effects of different vaccine formulations and adjuvants. [Vaccine] |
|
|
|
|
| The authors provide a comprehensive overview of rheumatoid arthritis, covering new research on the ‘pre-clinical’ phase of the disease, as well as its epidemiology, pathogenesis, clinical manifestations, diagnosis, imaging, and management strategies. [Panminerva Medica] |
|
|
|
|
| Marisol Gallagher, with Drs. Robert Wenham and Monica Avila, received a second round of CAR T-cell therapy 18 months after her first round. Her care team hopes the second infusion will cure her ovarian cancer once and for all. [Moffitt Cancer Center] |
|
|
|
|
| January 26-29, 2025 San Diego, California, United States |
|
|
|
|
|
| Cedars-Sinai Medical Center – Los Angeles, California, United States |
|
|
|
| University of Oxford – Oxford, England, United Kingdom |
|
|
|
| International Max Planck Research School for Infectious Diseases and Immunology – Berlin, Germany |
|
|
|
| Princeton University – Princeton, New Jersey, United States |
|
|
|
| Northwell Health – Manhasset, New York, United States |
|
|
|
|